Chester County News and Community Website
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has revealed plans to adopt a cryptocurrency policy, marking a significant step toward integrating digital finance into its operations. The policy will …
Windtree Therapeutics Announces Move into Cryptocurrency Payments and Holdings Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled key clinical efficacy data for rigosertib, showcasing its potential as a treatment for squamous cell carcinoma (SCC) associated with recessive …
Traws Pharma Announces Promising Clinical Data for Rigosertib in Rare Cancer Read More
LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD), through its subsidiary Ten Events, Inc., has announced the launch of an Early Adopter Program for its software-as-a-service (SaaS) product, Ten Events …
TEN Holdings Launches Early Adopter Program for New SaaS Platform Ten Events Pro Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced receiving a Refuse-to-File (RTF) letter from the U.S. Food and Drug Administration (FDA) for its Biologics License Application (BLA) of MOLBREEVI, …
FDA Requests Additional Data for Savara’s MOLBREEVI Application Read More LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD) has revealed its upcoming participation in several high-profile investor-focused conferences and webinars in June 2025. These engagements aim to boost the company’s …
TEN Holdings to Participate in Key Investor Events Throughout June 2025 Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) announced receipt of key guidance from the U.S. Food and Drug Administration (FDA) regarding the development of its investigational antiviral, tivoxavir marboxil …
Traws Pharma Receives FDA Feedback on Flu Drug Development Read More LANGHORNE, PA —Savara Inc. (Nasdaq: SVRA) announced the grant of inducement awards to five new employees.
Savara Inc. Grants Equity Awards to New Employees Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company, announced its management team will host 1×1 meetings and present at the Jefferies Global Healthcare Conference on June 4, …
Savara Inc. to Present at Jefferies Global Healthcare Conference on June 4, 2025 Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) unveiled significant findings from its Phase 3 IMPALA-2 clinical trial of molgramostim during two poster presentations at the ATS International Conference 2025. The …
Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 Read More
NEWTOWN, PA — Anthony Petsis & Associates, Inc. has achieved a noteworthy milestone, with all four of its financial advisors recognized as InvestmentNews 5-Star Financial Planners for 2025. This recognition …
Anthony Petsis & Associates Celebrates InvestmentNews 5-Star Financial Planners Recognition Read More